Odonate Therapeutics, Inc. (NASDAQ:ODT) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
Certain directors of Odonate Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.
View full press release